Typhoid Antibody Testing Market Report 2026

Typhoid Antibody Testing Market Overview

• Typhoid Antibody Testing market size has reached to $8.45 billion in 2025 • Expected to grow to $11.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Increase In Waterborne Diseases Driving Typhoid Antibody Testing Market Growth • Market Trend: Advances In Molecular Diagnostic Tests For Typhoid Fever • Asia-Pacific was the largest region in 2025.

What Is Covered Under Typhoid Antibody Testing Market?

Typhoid antibody testing is a diagnostic procedure designed to detect antibodies against Salmonella enterica serotype Typhi, the bacterium responsible for causing typhoid fever. The primary aim of typhoid antibody testing is to diagnose typhoid fever by identifying the immune response (antibodies) to Salmonella Typhi. Typhoid antibody testing helps to provide timely and accurate diagnosis, enabling appropriate treatment and management of the disease. The main types of products in typhoid antibody testing market are rapid serological tests, hem-agglutination and co-agglutination, counter immunoelectrophoresis, typhidot test, and widal test. Rapid serological tests are diagnostic tools used to quickly detect the presence of antibodies or antigens in a patient's blood sample. The various types of paratyphi included paratyphi A, paratyphi B, and paratyphi C. They are used by different end-users, such as hospitals, serological testing centers, clinics, diagnostic centers, and others.

What Is The Typhoid Antibody Testing Market Growth Forecast?

The typhoid antibody testing market size is expected to see strong growth in the next few years. It will grow to $11.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for rapid and accurate diagnostics, expansion of decentralized testing facilities, rising investments in advanced immunoassay technologies, growing focus on outbreak preparedness, increasing adoption of digital laboratory systems. Major trends in the forecast period include increasing adoption of rapid diagnostic test kits, rising demand for point-of-care typhoid testing, growing use of elisa-based assays, expansion of laboratory automation in diagnostics, enhanced focus on early disease detection.

What Is The Driver Of The Typhoid Antibody Testing Market?

The rise in waterborne diseases is expected to propel the growth of the typhoid antibody testing market going forward. Waterborne diseases refer to illnesses caused by pathogenic microorganisms transmitted through contaminated water. The rise in waterborne diseases is driven by poor sanitation and hygiene, lack of access to clean drinking water, rapid urbanization, climate change, and agricultural runoff. The typhoid antibody testing supports this rise by enabling early diagnosis, confirmation, and monitoring of treatment efficacy, thereby aiding in identifying carriers of typhoid fever and facilitating preventive measures for waterborne infections. For instance, in May 2023, according to the Coalition against Typhoid (a US-based organization dedicated to preventing typhoid and other invasive salmonellosis), the Philippines recorded 4,440 typhoid cases from January 1 to April 15 2023 marking a 77 % increase compared to the same period in 2022. Therefore, the rise in waterborne diseases is driving the growth of the typhoid antibody testing industry.

Key Players In The Global Typhoid Antibody Testing Market

Major companies operating in the typhoid antibody testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Sekisui Diagnostics, CTK Biotech Inc., Creative Diagnostics, Fortress Diagnostics Ltd., CerTest Biotec S.L, InBios International Inc., J. Mitra & Co. Pvt. Ltd, AccuBioTech Co. Ltd, Vanguard Diagnostics Pvt. Ltd., Suburban Diagnostics India Private Limited, Biorex Diagnostics, Genebio Healthcare Private Limited, ICT Diagnostics

Global Typhoid Antibody Testing Market Trends and Insights

Major companies operating in the typhoid antibody testing market are focused on developing innovative products, such as molecular diagnostic tests, to enhance the accuracy and speed of typhoid fever diagnosis. Molecular diagnostic tests offer high sensitivity and specificity, allowing for accurate and rapid detection of pathogens like Salmonella Typhi in cases of typhoid fever. For instance, in April 2023, Vanguard Diagnostics, an India-based diagnostic reagent developer, launched the VANSCAN typhoid RT PCR test, a molecular diagnostic test using its patented technology. It is designed to detect and diagnose typhoid fever through a real-time PCR (RT-PCR) testing approach, which is more accurate and sensitive than traditional serological tests. The VANSCAN Typhoid RT PCR Test marks a significant advancement in typhoid diagnostics, establishing a new gold standard for early, accurate, and reliable disease detection in India and globally.

What Are Latest Mergers And Acquisitions In The Typhoid Antibody Testing Market?

In January 2023, SD Biosensor, Inc., a South Korea‑based healthcare technology (in‑vitro diagnostics) company, and SJL Partners LLC, a South Korea‑based private equity firm, acquired Meridian Bioscience, Inc. for approximately $1.53 billion. With this acquisition, the two companies aim to accelerate their entry into the U.S. in-vitro diagnostics market by combining their manufacturing and R&D strengths with Meridian’s U.S. distribution network and regulatory expertise. Meridian Bioscience Inc. is a US-based life science company that provides typhoid antibody testing through a rapid immunoassay product called TruQuick Typhoid.

What Defines the Typhoid Antibody Testing Market?

The typhoid antibody testing market consists of sales of immunochromatographic tests, western blot, and typhoid test strips. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Typhoid Antibody Testing Market Report 2026?

The typhoid antibody testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the typhoid antibody testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.